Nanotechnology
Nanotechnology is paving the way for more precise and effective cancer treatments. Discover how nanoparticles are being used to target tumors, deliver drugs, and enhance diagnostic techniques.
Disrupting the RBM42 protein could throw a wrench in the gears of cancer’s growth
For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, UCSF scientists think they can throw a wrench into the fabrication of a key growth-related protein, MYC, that escalates wildly in 70% of all cancers. Unlike some other targets of cancer therapies, MYC can be dangerous simply due to its abundance.
Research shows deep cause of cancer development
Research shows deep cause of cancer development
Ultra-processed food? Forever chemicals? Declining birth rates? What’s behind rising cancer in the under-50s?
Research into the disease has never been more far-reaching, but there is little consensus as to what is causing the rocketing rates of diagnosis in young adults
Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
FRIDAY, Jan. 24, 2025 (HealthDay News) — Incorporating multiparametric magnetic resonance imaging (mpMRI) for initial staging can reduce the time to correct tr
Triangulate Labs uses AI for skin cancer detection device – South Florida Business Journal
Last year, it entered into a licensing agreement with the Mayo Clinic to test its technology.
FDA Approves Datroway for Pretreated Advanced Breast Cancer
In trial, datopotamab deruxtecan increased progression-free survival by 2 months
Nanoparticle Therapy Offers New Hope for Prostate Cancer Patients | University of Virginia School of Engineering and Applied Science
Prostate cancer is the second leading cause of cancer death among American men.
Toxic glass kills 99% of bone cancer without harming healthy cells
Scientists have demonstrated a new potential treatment for bone cancer. A bioactive glass laced with a toxic metal was able to kill up to 99% of the cancer without harming healthy cells, and could even help regrow healthy bone after.
Putting a lid on excess cholesterol to halt bladder cancer cell growth
Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a lid on their growth?
RAD51 testing shows promise in personalized early breast cancer treatment
Published in Clinical Cancer Research, results of a VHIO-led study underscore the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early breast cancer.
Omitting Axillary Lymph Node Dissection in Early Breast Cancer
Two large trials, real-world data inform clinical decision-making
Phase III trial finds trastuzumab emtansine improves long-term survival in HER2 breast cancer
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and improved survival compared to trastuzumab alone, according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center.
